•  
  •  
  •  
  •  

2025-12-02 16:31:35

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Venwind Refex Power Ltd included in ALMM by MNRE
  • NRB Bearings Limited announces JV with Italian industrial bearing manufacturer Unitec
  • Zaggle Prepaid Ocean Services Ltd enters into agreement with Pernod Ricard India Pvt Ltd
  • Moldtek Packaging signs MoU with Vibe Generation Holdings (UK) to produce High-Precision caps & Closures
  • KPI Green Energy Secures Landmark 142 MW (DC) / 110 MW (AC) Floating Solar EPC Contract from GSECL

Keywords Selected:  Injection

Stock Report

  • Lupin Receives Approval from U.S. FDA for Biosimilar Armlupeg - Pegfilgrastim-unne
  • Lupin Launches Liraglutide Injection in the United States
  • Wockhardt Submits New Drug Application to U.S. FDA for Zidebactam-Cefepime for Treatment of Serious GramNegative Infections
  • Glenmark Pharmaceuticals Inc., USA to launch Eribulin Mesylate Injection, 1mg/2Ml (0.5 mg/mL) Single-Dose Vials
  • Lupin Launches Glucagon for Injection USP, 1mg/Vial in the United States
  • Alembic Pharmaceuticals Ltd announces USFDA Final Approval for 20 mg/10 mL (2 mg/mL) and 50 mg/25 mL (2 mg/mL) Single-Dose Vials
  • Alembic Pharmaceuticals Ltd announces USFDA Final Approval for Pantoprazole Sodium for Injection, 40 mg/vial - Single-Dose Vial
  • Wockhardt files fast-acting Insulin Aspart injection with DCGI
  • Shilpa Medicare Ltd announces USFDA Approval for Bortezomib Injection NDA 212782
  • Alembic Pharmaceuticals announces USFDA Final Approval for Nelarabine Injection, 250 mg/50 mL
  • Caplin Steriles Ltd gets USFDA approval for Ephedrine Sulfate injection USP
  • Alembic Pharmaceuticals announces USFDA Tentative Approval for Selexipag for Injection, 1,800 mcg/vial
  • Alembic Pharmaceuticals announces USFDA Final Approval for Icatibant Injection, 30 mg/3 mL (10 mg/mL) Single-Dose Prefilled Syringe
  • Sun Pharma and Moebius Medical Ltd present Phase 2b study on MM-II
  • Cairn Oil & Gas commences India's largest commercial ASP injection in Mangala, Rajasthan
  • Gland Pharma receives approval for Edaravone Injection
  • Gland Pharma receives approval for Plerixafor for Injection
  • Gland Pharma receives approval for Cetrorelix Acetate for Injection
  • Gland Pharma receives approval for Eribulin Mesylate Injection
  • Zydus receives Final Approval from the USFDA for Chlorpromazine Hydrochloride Injection USP, 25 mg/mL and 50 mg/2 mL (25 mg/mL), Single-Dose Vials
  • Zydus receives Tentative Approval from the USFDA for Edaravone Injection, 30 mg/100 mL (0.3 mg/mL), Single-Dose Vial
  • Lupin Launches Ganirelix Acetate Injection in the United States
  • Eugia Pharma Specialities Ltd receives USFDA final approval for Posaconazole Injection
  • Zydus receives Final Approval from the USFDA for Methylene Blue Injection

Latest Post

  • Venwind Refex Power Ltd included in ALMM by MNRE
  • NRB Bearings Limited announces JV with Italian industrial bearing manufacturer Unitec
  • Zaggle Prepaid Ocean Services Ltd enters into agreement with Pernod Ricard India Pvt Ltd
  • Moldtek Packaging signs MoU with Vibe Generation Holdings (UK) to produce High-Precision caps & Closures
  • KPI Green Energy Secures Landmark 142 MW (DC) / 110 MW (AC) Floating Solar EPC Contract from GSECL


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024